| (CCTG) CO.21 / CHALLENGE | A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patients With High Risk Stage II or Stage III Colon Cancer: A Randomized Controlled Trial (CHALLENGE) | Dr John Goffin | Suspended/On hold | NCT00819208 |
| (CCTG) PAC.3 / ALLIANCE A021806 | A Phase III Trial of Perioperative versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer | Dr Pablo Serrano | Open to recruitment | NCT04340141 |
| (Deciphera) DCC-2618-03-003 / INSIGHT | An International, Phase 3, Randomized, Multicenter, Open label Study of Ripretinib vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumor (GIST) with KIT Exon 11 and Co-occurring KIT Exons 17 and/or 18 Mutations Who Were Previously Treated with Imatinib | Dr Kevin Zbuk | Open to recruitment | NCT05734105 |
| (Roche) CO44668 / IMbrave152 | A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING ATEZOLIZUMAB AND BEVACIZUMAB, WITH AND WITHOUT TIRAGOLUMAB, IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA. | Dr Brandon Meyers | Open to recruitment | NCT05904886 |
| OCOG-2021-ADVANCE HCC | Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy Prior to Hepatectomy in Hepatocellular Carcinoma with Portal Vein Tumour Thrombus (ADVANCE HCC) | Dr Brandon Meyers | Suspended/On hold | NCT05137899 |
Find a Trial
Contact Us